BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 9659645)

  • 1. Intrauterine cocaine and crack exposure: neonatal outcome.
    Datta-Bhutada S; Johnson HL; Rosen TS
    J Perinatol; 1998; 18(3):183-8. PubMed ID: 9659645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detrimental effects of prenatal cocaine exposure: illusion or reality?
    Richardson GA; Day NL
    J Am Acad Child Adolesc Psychiatry; 1994 Jan; 33(1):28-34. PubMed ID: 8138518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal cocaine and neonatal outcome: evaluation of dose-response relationship.
    Delaney-Black V; Covington C; Ostrea E; Romero A; Baker D; Tagle MT; Nordstrom-Klee B; Silvestre MA; Angelilli ML; Hack C; Long J
    Pediatrics; 1996 Oct; 98(4 Pt 1):735-40. PubMed ID: 8885954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cocaine-exposed preterm neonates show behavioral and hormonal differences.
    Scafidi FA; Field TM; Wheeden A; Schanberg S; Kuhn C; Symanski R; Zimmerman E; Bandstra ES
    Pediatrics; 1996 Jun; 97(6 Pt 1):851-5. PubMed ID: 8657526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cohort study of alkaloidal cocaine ("crack") in pregnancy.
    Cherukuri R; Minkoff H; Feldman J; Parekh A; Glass L
    Obstet Gynecol; 1988 Aug; 72(2):147-51. PubMed ID: 3393357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute neonatal effects of cocaine exposure during pregnancy.
    Bauer CR; Langer JC; Shankaran S; Bada HS; Lester B; Wright LL; Krause-Steinrauf H; Smeriglio VL; Finnegan LP; Maza PL; Verter J
    Arch Pediatr Adolesc Med; 2005 Sep; 159(9):824-34. PubMed ID: 16143741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-year outcome of children exposed prenatally to drugs.
    Griffith DR; Azuma SD; Chasnoff IJ
    J Am Acad Child Adolesc Psychiatry; 1994 Jan; 33(1):20-7. PubMed ID: 7511139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Birth outcome from a prospective, matched study of prenatal crack/cocaine use: II. Interactive and dose effects on neurobehavioral assessment.
    Eyler FD; Behnke M; Conlon M; Woods NS; Wobie K
    Pediatrics; 1998 Feb; 101(2):237-41. PubMed ID: 9445497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating catecholamine concentrations in cocaine-exposed neonates: a pilot study.
    Mirochnick M; Meyer J; Cole J; Herren T; Zuckerman B
    Pediatrics; 1991 Sep; 88(3):481-5. PubMed ID: 1909023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perinatal cocaine effects on neonatal stress behavior and performance on the Brazelton Scale.
    Eisen LN; Field TM; Bandstra ES; Roberts JP; Morrow C; Larson SK; Steele BM
    Pediatrics; 1991 Sep; 88(3):477-80. PubMed ID: 1881726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-care utilization among mothers and infants following cocaine exposure.
    Shankaran S; Bauer CR; Bada HS; Lester B; Wright LL; Das A
    J Perinatol; 2003; 23(5):361-7. PubMed ID: 12847529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cocaine: how dangerous is it during pregnancy?
    Buehler BA
    Nebr Med J; 1995 May; 80(5):116-7. PubMed ID: 7791943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Birth outcome from a prospective, matched study of prenatal crack/cocaine use: I. Interactive and dose effects on health and growth.
    Eyler FD; Behnke M; Conlon M; Woods NS; Wobie K
    Pediatrics; 1998 Feb; 101(2):229-37. PubMed ID: 9445496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy outcome and infant development following gestational cocaine use by social cocaine users in Toronto, Canada.
    Graham K; Feigenbaum A; Pastuszak A; Nulman I; Weksberg R; Einarson T; Goldberg S; Ashby S; Koren G
    Clin Invest Med; 1992 Aug; 15(4):384-94. PubMed ID: 1516296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurobehavioral profiles of neonates exposed to cocaine prenatally.
    Mayes LC; Granger RH; Frank MA; Schottenfeld R; Bornstein MH
    Pediatrics; 1993 Apr; 91(4):778-83. PubMed ID: 8464666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost of maternal cocaine abuse: I. Perinatal cost.
    Calhoun BC; Watson PT
    Obstet Gynecol; 1991 Nov; 78(5 Pt 1):731-4. PubMed ID: 1923187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of substance abuse during pregnancy and infant outcome.
    Little BB; Snell LM; Van Beveren TT; Crowell RB; Trayler S; Johnston WL
    Am J Perinatol; 2003 Jul; 20(5):255-62. PubMed ID: 13680509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromotor development of cocaine-exposed and control infants from birth through 15 months: poor and poorer performance.
    Fetters L; Tronick EZ
    Pediatrics; 1996 Nov; 98(5):938-43. PubMed ID: 8909489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal cocaine exposure. A longitudinal study of development.
    Richardson GA
    Ann N Y Acad Sci; 1998 Jun; 846():144-52. PubMed ID: 9668403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal cocaine exposure and prolonged focus attention. Poor infant information processing ability or precocious maturation of attentional systems?
    Chiriboga CA; Starr D; Kuhn L; Wasserman GA
    Dev Neurosci; 2009; 31(1-2):149-58. PubMed ID: 19372695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.